Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$5.78 - $8.87 $1,734 - $2,660
-300 Reduced 2.83%
10,298 $82,000
Q1 2022

May 11, 2022

BUY
$5.14 - $9.35 $54,473 - $99,091
10,598 New
10,598 $66,000
Q3 2021

Nov 02, 2021

SELL
$10.35 - $15.65 $251,970 - $380,999
-24,345 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$12.25 - $14.87 $42,593 - $51,702
3,477 Added 16.66%
24,345 $378,000
Q1 2021

May 14, 2021

BUY
$12.28 - $19.74 $256,259 - $411,934
20,868 New
20,868 $319,000
Q4 2019

Feb 12, 2020

SELL
$6.94 - $11.37 $83,106 - $136,155
-11,975 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$6.69 - $9.65 $669 - $965
100 Added 0.84%
11,975 $114,000
Q2 2019

Aug 06, 2019

BUY
$4.23 - $10.66 $50,231 - $126,587
11,875 New
11,875 $107,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $308M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.